A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020Saori Nishio, Ichiei Narita, Kiyotaka Uchiyama et al.|Clinical and Experimental Nephrology|2021Cited by 28
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD)Kiyotaka Uchiyama, Satoru Muto, Toshio Mochizuki et al.|Clinical and Experimental Nephrology|2021Cited by 16
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Satoru Muto, Yosuke Shimada et al.|Clinical and Experimental Nephrology|2023Cited by 5
Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Satoru Muto, Yosuke Shimada et al.|Clinical and Experimental Nephrology|2023Cited by 0
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP)Shinya Nakatani, Shuichiro Fujinaga, Haruna Kawano et al.|Clinical and Experimental Nephrology|2024Cited by 0